JP2023547313A5 - - Google Patents
Info
- Publication number
- JP2023547313A5 JP2023547313A5 JP2023518033A JP2023518033A JP2023547313A5 JP 2023547313 A5 JP2023547313 A5 JP 2023547313A5 JP 2023518033 A JP2023518033 A JP 2023518033A JP 2023518033 A JP2023518033 A JP 2023518033A JP 2023547313 A5 JP2023547313 A5 JP 2023547313A5
- Authority
- JP
- Japan
- Prior art keywords
- herv
- binding protein
- protein according
- antibody
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026005255A JP2026098922A (ja) | 2020-09-17 | 2026-01-15 | Ｈｅｒｖ－ｋ抗体治療薬 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080009P | 2020-09-17 | 2020-09-17 | |
| PCT/US2021/071505 WO2022061368A2 (en) | 2020-09-17 | 2021-09-18 | Herv-k antibody therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026005255A Division JP2026098922A (ja) | 2020-09-17 | 2026-01-15 | Ｈｅｒｖ－ｋ抗体治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547313A JP2023547313A (ja) | 2023-11-10 |
| JP2023547313A5 true JP2023547313A5 (cg-RX-API-DMAC10.html) | 2024-10-03 |
| JP7810446B2 JP7810446B2 (ja) | 2026-02-03 |
Family
ID=80776422
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518033A Active JP7810446B2 (ja) | 2020-09-17 | 2021-09-18 | Ｈｅｒｖ－ｋ抗体治療薬 |
| JP2024516706A Pending JP2024541175A (ja) | 2020-09-17 | 2022-09-16 | Ｈｅｒｖ－ｋ抗体治療法 |
| JP2026005255A Pending JP2026098922A (ja) | 2020-09-17 | 2026-01-15 | Ｈｅｒｖ－ｋ抗体治療薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516706A Pending JP2024541175A (ja) | 2020-09-17 | 2022-09-16 | Ｈｅｒｖ－ｋ抗体治療法 |
| JP2026005255A Pending JP2026098922A (ja) | 2020-09-17 | 2026-01-15 | Ｈｅｒｖ－ｋ抗体治療薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20240059787A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4213881A4 (cg-RX-API-DMAC10.html) |
| JP (3) | JP7810446B2 (cg-RX-API-DMAC10.html) |
| CN (2) | CN116457018A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3195886A1 (cg-RX-API-DMAC10.html) |
| WO (2) | WO2022061368A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024148216A2 (en) * | 2023-01-05 | 2024-07-11 | Neximmune, Inc. | Combination therapy with t cell engager |
| WO2025222129A2 (en) * | 2024-04-19 | 2025-10-23 | Mozart Therapeutics, Inc. | Engineered cytokines and targeted cytokine delivery |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060275747A1 (en) * | 2001-12-07 | 2006-12-07 | Hardy Stephen F | Endogenous retrovirus up-regulated in prostate cancer |
| US20090297530A1 (en) * | 2006-05-22 | 2009-12-03 | Feng Wang-Johanning | Herv-k antigens, antibodies, and methods |
| US20080019979A1 (en) * | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US20110091544A1 (en) | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| TWI487537B (zh) * | 2010-06-09 | 2015-06-11 | Nat Health Research Institutes | 對抗腸病毒７１型之單株抗體及其用途 |
| WO2012058137A2 (en) * | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | Methods for diversifying antibodies, antibodies derived therefrom and uses thereof |
| EP2997134B1 (en) * | 2013-05-14 | 2020-06-24 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CA2927022C (en) | 2013-10-11 | 2018-08-21 | Asana Biosciences, Llc | Protein-polymer-drug conjugates |
| US12016882B2 (en) * | 2017-11-22 | 2024-06-25 | The Brigham And Women's Hospital, Inc. | Method of treating glioblastoma multiforme |
| WO2020069433A1 (en) * | 2018-09-28 | 2020-04-02 | Imaginab, Inc. | Cd8 imaging constructs and methods of use thereof |
| US20250145693A1 (en) * | 2021-09-18 | 2025-05-08 | Sunnybay Biotech, Inc. | Herv-k antibody, cell, vaccine, and drug therapeutics |
-
2021
- 2021-09-18 JP JP2023518033A patent/JP7810446B2/ja active Active
- 2021-09-18 EP EP21870462.5A patent/EP4213881A4/en active Pending
- 2021-09-18 CA CA3195886A patent/CA3195886A1/en active Pending
- 2021-09-18 US US18/245,879 patent/US20240059787A1/en active Pending
- 2021-09-18 CN CN202180077370.3A patent/CN116457018A/zh active Pending
- 2021-09-18 WO PCT/US2021/071505 patent/WO2022061368A2/en not_active Ceased
-
2022
- 2022-09-16 JP JP2024516706A patent/JP2024541175A/ja active Pending
- 2022-09-16 US US18/692,754 patent/US20240374644A1/en active Pending
- 2022-09-16 EP EP22871001.8A patent/EP4401779A4/en active Pending
- 2022-09-16 WO PCT/US2022/076624 patent/WO2023044465A1/en not_active Ceased
- 2022-09-16 CN CN202280062721.8A patent/CN118103071A/zh active Pending
-
2026
- 2026-01-15 JP JP2026005255A patent/JP2026098922A/ja active Pending